The impact of anaemia and its treatment on employee disability and medical costs

PharmacoEconomics

Volumn 23, Issue 2, 2005, Pages 183-192

  Berndt, Ernst ^a   Crown, William ^b   Kallich, Joel ^c   Long, Stacey ^d   Song, Xue ^e   Lyman, Gary H ^f  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MEDSTAT GROUP   (United States)

^c AMGEN INC   (United States)

^d Medstat Inc   (United States)

^e MEDSTAT Group   (United States)

^f UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DISABILITY; EMPLOYEE; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANEMIA; COST OF ILLNESS; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS;

EID: 16244417459     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200523020-00009     Document Type: Article

References (25)

1. Bron D, Meuleman N, Mascaux C. Biological basis of anemia. Semin Oncol 2001; 28 (2 Suppl. 8): 1-6
2. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999; 91: 1616-34
3. Ziegler J. When cancer comes to work. Business and Health 1998; 16(7): 34-7
4. Carelle N, Piotto E, Bellanger A, et al. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002; 95: 155-63
5. Berndt E, Kallich J, McDermot A et al. Reductions in anaemia and fatigue are associated with improvements in productivity. PharmacoEconomics. In press.
6. Broadhead WE, Blazer DG, George LK, et al. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990; 264: 2524-8
7. Comstock GW, Stone RW, Tonascia JA, et al. Respiratory survey findings as predictors of disability from respiratory diseases. Am Rev Respir Dis 1981; 124 (4): 367-71
8. Crystal-Peters J, Crown WH, Goetzel RZ, et al. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000; 6: 373-8
9. Persson U. The indirect costs of morbidity in type II diabetic patients. Pharmacoeconomics 1995; 8 Suppl. 1: 28-32
10. Guo HR, Tanaka S, Halperin WE, et al. Back pain prevalence in US industry and estimates of lost workdays. Am J Public Health 1999; 89 (7): 1029-35
11. Rapoport AM, Adelman JU. Cost of migraine management: a pharmacoeconomic overview. Am J Manag Care 1998; 4 (4): 531-45
12. Michel P, Dartigues JF, Duru G, et al. Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort. Cephalalgia 1999; 19 (5): 503-10
13. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999; 1999: 813-8
14. Oxterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labor costs of migraine headache in the US. Pharmacoeconomics 1992; 2(1): 67-76
15. Cremieux PY, Slavin MB, Fendrick M, et al. The costs of cancer: cancer-related conditions can add dramatically to overall costs of care. J Manag Care Med 2002; 6 (1): 12-9
16. D'Hoore W, Bouckaert A, Tilquin C. Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 1996; 49: 1429-33
17. Goetzel RZ, Hawkins K, Ozminkowski RJ, et al. The health and productivity cost burden of the 'top 10' physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 2003; 45: 5-14
18. Pauly MV, Nicholson S, Xu J, et al. A general model of the impact of absenteeism on employers and employees. Health Econ 2002; 11: 221-31
19. Manning WG, Newhouse JP, Duan N, et al. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev 1987; 77: 251-77
20. Duan N, Manning W, Morris C, et al. A comparison of alternative models for the demand for medical care. JBES 1983; 2 (1): 115-26
21. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983; 78: 605-10
22. Cameron AC, Trivedi PK. Regression analysis of count data. New York: Cambridge University Press, 1998
23. Barnett A, Cremieux PY, Fendrick AM, et al. Anemia-related costs for cancer patients. J Manag Care Med 2002; 6 (1): 20-8
24. Schrag D. The price tag on progress: chemotherapy for colorectal cancer. N Engl J Med 2004; 351: 317-9
25. Varmus H. Disease-specific estimates of direct and indirect costs of illness and NIH support. Bethesda (MD): US Department of Health and Human Services, National Institutes of Health, 1997 Sep